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The aim of this study was to compare results obtained by eight different short-term assays of
estrogenlike actions of chemicals conducted in 10 different laboratories in five countries. Twenty
chemicals were selected to represent direct-acting estrogens, compounds with estrogenic
metabolites, estrogenic antagonists, and a known cytotoxic agent. Also included in the test panel
were 17,Bestradiol as a positive control and ethanol as solvent control. The test compounds were
coded before distribution. Test methods included direct binding to the estrogen receptor (ER),
proliferation of MCF-7 cells, transient reporter gene expression in MCF-7 cells, reporter gene
expression in yeast strains stably transfected with the human ER and an estrogen-responsive
reporter gene, and vitellogenin production in juvenile rainbow trout. 17p-Estradiol, 177a-ethynyl
estradiol, and diethylstilbestrol induced a strong estrogenic response in all test systems.
Colchicine caused cytotoxicity only. Bisphenol A induced an estrogenic response in all assays.
The results obtained for the remaining test compounds-tamoxifen, ICI 182.780, testosterone,
bisphenol A dimethacrylate, 4-n-octylphenol, 4-n-nonylphenol, nonylphenol dodecylethoxylate,
butylbenzylphthalate, dibutylphthalate, methoxychlor, o,p'-DDT, p,p'-DDE, endosulfan,
chlomequat chloride, and ethanol-varied among the assays. The results demonstrate that
careful standardization is necessary to obtain a reasonable degree of reproducibility. Also, similar
methods vary in their sensitivity to estrogenic compounds. Thus, short-term tests are useful for
screening purposes, but the methods must be further validated by additional interlaboratory and
interassay comparisons to document the reliability of the methods. - Environ Health Perspect
107(Suppl 1):89-108 (1999). http://ehpnetl.niehs.nih.gov/docs/1999/Suppl-1/89-108andersen/
abstract.html
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Several man-made chemicals that are and the toxicology of the substances are
widely distributed in the environment may poorly understood.
have the potential to mimic estrogens or Estrogenic chemicals identified to date
otherwise disrupt the endocrine system include some organochlorine pesticides,
(1-4). Reliable short-term methods are such as o,p'-DDT and methoxychlor, and
needed to identify such chemicals, to char- industrial chemicals and byproducts,
acterize and control the environmental including some polychlorinated biphenyl
load, and to evaluate human exposures. congeners, alkyl phenols, phthalates, and
Attempts to develop these methods must bisphenol A (5-8). The chemical structure
confront the problem that the biologic fate of these chemicals varies substantially,
which makes it difficult to predict their
estrogenicity solely on a structural basis.
Estrogenicity was first defined as a
physiologic response to a compound that
induced estrus in vivo. An in vivo rodent
uterine bioassay was developed in which an
estrogen-induced uterotropic response was
estimated as an increase in uterine tissue
mass in ovariectomized or immature
rodents (9). This assay is often regarded as
a gold standard. However, although it has
been widely used for many years, the assay
has still not been fully standardized (10),
and even when the same protocol is used,
the results sometimes vary between differ-
ent laboratories (11,12). Finally, different
tissues may respond differently to estro-
genic chemicals. A well-known example is
tamoxifen, an antiestrogen in breast tissue
but a uterotropic estrogenic agonist in
uterine tissue (13). More broadly based in
vivo assays should aim at detecting the
response in different tissues, thereby
becoming more sensitive and informative.
The advantages of the rodent utero-
tropic assay and other in vivo assays are that
they take into consideration the effects of
metabolism, plasma-protein binding, and
pharmacokinetics. These methods can also
detect estrogenic responses due to altered
metabolism ofexogenous or endogenous
estrogens as caused by, for example, some
hepatotoxic chemicals such as carbon tetra-
chloride (14). However, in vivomethods are
in general expensive and time-consuming,
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and a variety ofshort-term assays are there-
fore being applied to identify estrogenic
chemicals and to determine the relative
potencies for hormonal responses. Some of
these assays may be suitable for screening
large numbers ofchemicals and contami-
nated media, such as water and food, and
may therefore be useful tools for priori-
tizing chemicals for more extensive studies
in vivo.
However, most in vitro assays estimate
primarily the intrinsic estrogenic activity
ofthe chemicals as reflected by their bind-
ing to and activation ofthe estrogen recep-
tor (ER) without taking into account
factors that may affect their activity in the
intact organism. These factors include:
binding afflnity of the chemical to pro-
teins (especially sex-hormone binding
globulin [SHBG] and albumin), ability to
enter target cells, degradation time in the
organism, and the concentration of
endogenous estrogen.
Most circulating endogenous estrogen
(>99%) is bound to plasma proteins and
only a minor fraction is able to penetrate
into the cells and activate the ER. Estro-
genic chemicals such as o,p'-DDT, octyl-
phenol (15), bisphenol A (16), and the
potent synthetic estrogen diethylstilbestrol
(DES) (15,1/) have a much lower affinity
for these proteins than does 17p-estradiol.
Hence, the major part ofthese chemicals in
the blood would be available for activation
ofthe cellular ER. The relative potency of
the chemicals compared to estradiol may
therefore be underestimated by in vitro tests
conducted without addition ofplasma pro-
teins, as has recendy been demonstrated for
bisphenolA (16).
The biodegradation of estrogenic
chemicals may influence the estrogenic
response, as a long degradation time could
enhance the response. Some environmental
chemicals are very lipophilic and resistant
to metabolism and may therefore accumu-
late in organisms and reach concentrations
sufficient to produce estrogenic responses
in vivo. Hence, although the environmen-
tal estrogens characterized to date are con-
siderably less potent than estradiol (1/50th
to 1/10000th) based on ER binding affini-
ties or effects seen in cell cultures (5,18),
low concentrations may still be detrimental
to the reproductive success of exposed
organisms. For example, feminization and
decreased reproduction in gulls was appar-
endy elicited by o,p'-DDT in eggs at con-
centrations as low as 5 mg/kg, which is
similar to concentrations reported in the
environment (19).
Because estrogenic chemicals compete
with endogenous estrogens for binding to
ERs, the concentration ofendogenous estro-
gen may influence the estrogenic effects of
the chemicals, and a chemical that on its
own shows a weak estrogenicity might
therefore potentially act as an antiestrogen
in vivo. Inaddition, humans andwildlife are
exposed to several potential estrogenic
chemicals simultaneously. Addition of two
or moreweakestrogens mayinduce an addi-
tive effect, as demonstrated in MCF-7 cells
(5) andbyinduction ofvitellogenin in male
fish (20).
To obtain a reliable screening system for
estrogenicity, it is necessary to validate the
short-term assays and compare the results
to those obtained in different types of in
vivo studies. Further development ofthe
short-term assay systems may be needed,
and several assays may need to be combined
in a screening panel. As an important step
in this process, it is necessary to compare
and validate those short-term assays already
developed and used by different laborato-
ries. Therefore, a comparison study of
short-term tests for estrogenic activity of
chemicals was initiated. Previous studies
have compared the results obtained in
different assay systems using the same
chemicals within the same laboratory
(7,21-23). In this study, 10 laboratories
agreed to participate and test a panel of20
chemicals without knowing the identity of
the chemicals prior to testing.
The short-term methods were chosen
to represent different types of response.
Binding assays measure the specificbinding
to the ER but provide no information on
activation of the receptor. The prolifera-
tion assay in MCF-7 cells (E-SCREEN)
measures a cellular response known to be
induced by estrogens but reveals no direct
information of the mechanism involved.
The reporter gene expression assays detect
activation ofthe ERleading to binding of
an estrogen-responsive element (ERE) and
expression of a reporter gene. Several
reporter gene assays were included, i.e., a
mammalian cell type (MCF-7) transiently
transfected with ERE and a reporter gene
and different yeast assaysstably transfected
with ER and ERE-linked reporter genes.
Finally, an in vivo assayusing induction of
vitellogenin in juvenile rainbow trout was
included becausevitellogenin induction in
juvenile or male fish is reportedly a very
sensitive biologic marker for estrogenicity
(20). Several of the assays (e.g., the E-
SCREEN and the yeast assays) have been
widely used in an attempt to identify
estrogenic chemicals (5,8,24-28).
The test chemicals (Table 1; Figure 1)
were selected to represent documented
direct-acting potent estrogens (17p-estra-
diol, 17a-ethynyl estradiol, DES), a com-
plete antiestrogen (ICI 182.780), a partial
antiestrogen (tamoxifen), a potent andro-
gen (testosterone), and environmental pol-
lutants reported to be estrogenic in
different in vitro assays as well as in vivoby
inducing a uterotropic response in rodents.
The responses were induced eitherdirectly [i.e., octylphenol (OP) (15,27,29-31),
nonylphenol (NP) (12,23,27,31-35), and
o,p'-DDT (5,21,27,36-39)] or after
Table 1. Testchemicals.
Compound (CAS no.)
173-Estradiol (50-28-2)
17j3-Ethynyl estradiol (57-63-6)
Diethylstilbestrol (56-53-1)
Tamoxifen (10540-29-1)
ICI 182.780(129453-61-8)a
Testosterone (58-22-0)
Bisphenol A(80-05-7)
Bisphenol A-dimethacrylate (3253-39-2)
4-rn-Octylphenol(1806-26-4)
4-n-Nonylphenol (25154-52-3)
Nonylphenol dodecylethoxylate
Benzylbutylphthalate(85-68-7)
Dibutylphthalate(84-74-2)
Methoxychlor(72-43-5)
o,p'-DDT(789-02-6)
p,p'-DDE(72-55-9)
Endosulfan(mixed isomers)b(115-29-7)
Chlormequatchloride(999-81-5)
Colchicine (64-86-8)
Ethanol
Supplier(Code no.)
Sigma(E 1132)
Sigma (E0882)
Sigma(D4628)
Aldrich(28,161-1)
Zeneca
Sigma(T 1268)
Aldrich(23,965-8)
Aldrich(15,632-9)
Ehrenstorfer(C 157120)
Ehrenstorfer(C 156300)
Promochem
Riedel-deHaen(36927)
Riedel-de Haen(36736)
Ehrenstorfer(C 150600)
Ehrenstorfer(C120810)
Ehrenstorfer(C 120410)
Ehrenstorfer(C 131200)
Ehrenstorfer(Cl13400)
Sigma(C3915)
BDH(15338 SE)
Purity, %
99.4
99.1
99
96
99.3
100
99
99.7
99.4
99.9
7
97
98
98.4
99.8
99.7
99
97
95
99.8
?, unknown. aGiftfrom Zeneca Pharmaceuticals. h75% a-isomerand 24%13-isomer.
Test no.
A
B
C
D
E
F
G
H
J
K
L
M
N
0
p
0
R
S
T
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Figure 1. Chemical structure of the test compounds.
metabolism [i.e., methoxychlor (5,12,40)].
Other test compounds have been reported
estrogenic in vitro but not uterotropic in
vivo: benzylbutylphthalate (BBP), dibutyl-
phthalate (DPB) (6,23), and endosulfan
(5,41,42), and two of the test compounds
have been reported estrogenic in vitro, but
no information on uterotropic responses is
available: bisphenol A (8,27,28) and
bisphenol A-dimethacrylate (8). In addi-
tion, an antiandrogen [p,p'-DDE (43)], a
nonylphenolpolyethoxylate (nonylphenol
dodecylethoxylate [NP12EO]) that
degrades to NP (31), a chlorinated nonaro-
matic compound (chlormequat chloride), a
chemical with known cytotoxic effect
(colchicine), and ethanol as solvent control
were included.
Materials and Methods
Chemicals
The chemicals were obtained from Sigma
Chemical Company (St. Louis, MO),
Ehrenstorfer (Augsburg, Germany),
Riedel-de Haen (Seelze, Germany), Aldrich
(Steinheim, Germany), Promochem, (Wesel,
Germany), or Zeneca Pharmaceuticals
(Cheshire, UK), as listed in Table 1. The
purity of the chemicals stated in the table
was reported by the supplier.
Identical test panels consisting of 18
vials each containing approximately 2 ml
stock solutions of 10 mmole/liter ofthe test
substances were set up. All test compounds
were dissolved in pure ethanol from BDH
(Poole, UK). In addition, the test panel
included one vial containing 2-ml 10
imol/liter 17p-estradiol used as positive
control and one vial containing 2 ml pure
ethanol as solvent control. These test panels
were used for all assays except induction of
vitellogenin production in rainbow trout
because this assay required much more of
the test compounds. The same batches of
chemicals were used for this assay. The
chemicals were weighed, coded, and trans-
ferred to brown glass vials (10.0 ml, La-
Pha-Pack, Langerwerde, Germany) before
delivery to laboratory 9. The chemicals
were dissolved in laboratory 9. Details of
this assay are given below and in "Results."
All test compounds were weighed and
dissolved in ethanol and transferred to
brown glass vials (4.0 ml, La-Pha-Pack)
with screw caps of butyl gummy with
Teflon foliation (Brown Chromatography,
Wiirzburg, Germany). DES, 17ax-ethynyl
estradiol, and 17p-estradiol were handled
separately after all the other test com-
pounds were weighed and dissolved. As the
last step, ethanol for the solvent controls
was transferred directly to the test vials.
Because the solvent controls were prepared
after the strongly active estrogens, the risk
of cross-contamination was maximized,
although rigorous efforts were made to
limit this risk. All test vials were placed at
-20°C until their distribution to the par-
ticipating laboratories. During transport
the test vials were kept on dry ice. After
arrival the test panel was kept at -200C
until the analyses were performed. All par-
ticipating institutions were informed that
the test panel contained hazardous toxic
chemicals and should be handled accord-
ingly. The laboratories and methods are
summarized in Table 2.
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Table 2. Laboratories and methods included in the study
Laboratory name (laboratory no.)
Department of Environmental Medicine,
Odense University, Odense, Denmark (1)
Department of Anatomy and Cellular Biology,
Tufts University, Boston, Massachusetts (2)
Laboratory of Medical Investigation,
University of Granada, Granada, Spain (3)
Department of Biology and Biochemistry,
Brunel University, Uxbridge, Middlesex, UK(41
Laboratorie D'Endocrinologie Moleculaire de
la Reproduction, Campus de Beaulieu,
Rennes, Cedex, France (5)
Department of Growth and Reproduction,
The National University Hospital,
Copenhagen, Denmark (6)
Department of Environmental Medicine,
University of Arhus, Arhus, Denmark (7)
Novo Nordisk A/S, Malav, Denmark (8)
Department of Biology, Odense University,
Odense, Denmark (9)
Environmental Endocrinology Laboratory,
Tulane University, New Orleans, Louisiana (10)
Direct Competitive Estrogen in Vitro
BindingAssay (Laboratory 6) Based on
Recombinant Human Estrogen Receptor
Isolated by Reverse Transcriptase-
Polymerase Chain Reactionfrom MCF-7
Cells. The complete coding region of the
ER (amino acids 2 to 595) was prepared
by reverse transcriptase-polymerase chain
reaction (RT-PCR) from cDNA prepared
from total RNA from MCF-7 cells. cDNA
was synthesized from 1-pg total RNA
using 0.5-pg T14V primer (V corresponds
to A, C, or G) as described in Ausubel et
al. (44). One microliter of the cDNA
sample was used for PCR using 5 p native
Pfu-enzyme (Stratagene, La Jolla, CA)
including 30 pmol ofeach primer:
5'-primer: 5'-CGGGGATCCACCAT
GACCCTCCACACCAAAG-3';
3'-primer: 5'-GAGGAA TTCCGACT
GTGGCAGGGAAACCCTC-3'.
Nucleotides in italics were added to
facilitate cloning. The cycle conditions on a
GeneAmp PCR System 9600 (Perkin-
Elmer Corp., Norwalk, CT) were 960C for
3 min, followed by 40 cycles of96°C for 30
sec, 680C for 1 min, 740C for 3 min, and
finally, 740C for 8 min. The ligand-binding
domain (LBD) (amino acids 282 to 595)
was prepared from the complete coding
region DNA fragment by PCR as described
previously, except that the 5'-primer was
exchanged with 5'-GAAGGATCCTCT
GCTGGAGACATGAG-3' and only 15
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Test method
E-SCREEN, proliferation of MCF-7 cells
E-SCREEN, proliferation of MCF-7 cells
E-SCREEN, proliferation of MCF-7 cells
Recombinant yeast (Saccharomyces) estrogen screen
expressing hER
Recombinant yeast (Saccharomyces) estrogen screen
expressing rtER
Direct competitive estrogen in vitro binding assay,
recombinant hER
Recombinant yeast (Saccharomyces) estrogen
screen expressing hER
Transient gene expression assay in MCF-7 cells
In vitro ER binding assay, rabbit uterine tissue
Vitellogenin production in juvenile rainbow trouts
1n V/vo
Recombinant yeast (DY159) estrogen screen
expressing hER
cycles were performed using an annealing
temperature of 520C. The resulting DNA
fragments were digested with restriction
enzymes BamHI and EcoRI and cloned
directionally into pGEX GTH (45), allow-
ing 32P-end labeling of the Est-LBD. The
insert in the purified plasmid DNA wvas
sequenced on an ALFexpress sequenator
(Amersham-Pharmacia-Bioteck, Uppsala,
Sweden) using the ThermoSequenase
(Amersham-Pharmacia-Bioteck) and CY5
fluorescence labeled primers. The recombi-
nant proteins were purified as glutathione
S-transferase (GST) fusion proteins from
Escherichia coli lysates, using the bulk GST
purification module as described by the
manufacturer (Amersham-Pharmacia-
Bioteck). To normalize the amount of
fusion protein used in each assay, an aliquot
of the Sepharose-GST-LBD (about 5% of
total amount used) was 32p labeled with
[y32P]adenosine triphosphate (Amersham-
Pharmacia-Bioteck) and 2.5-p bovine heart
muscle kinase (Sigma Chemical) as
described by the manufacturer (Amersham-
Pharmacia-Bioteck) and then mixed 1:20
(vol:vol) with the unlabeled Sepharose-
GST-LBD, resulting in approximately
200 cpm/10 pl.
In the binding assay, 10 pl aliquots of
Sepharose-GST-LBD mixed with [32p]_
labeled Sepharose-GST-LBD were trans-
ferred to Eppendorf tubes (Eppendorf-
Netheler-Hinz GmbH, Hamburg, Germany)
and 1 xphosphate-buffered saline (PBS)
(140 mM NaCI, 2.7 mM KCI, 10.1 mM
Na2HPO4, 1.8 mM KH2PO4; pH 7.3) was
added to a final volume of 48 pl. All the
chemicals were diluted in 96% ethanol to
the desired concentrations and mixed 1:1
with 3H-estradiol (10 pCi/ml). Two micro-
liters of this mixture was added to the
Sepharose-GST-1BD beads and incubated
at room temperature for 45 min with slow
agitation. The beads were collected by cen-
trifugation and washed four times with 500-
pl 1 x PBS before they were resuspended in
50-pl 1 x PBS and transferred to 5 ml
Ultima Gold scintillation solution (Packard
Instrument Co., Meriden, CT) and mea-
sured in a scintillation counter measuring
both 3H-estradiol and 32P activity. The
[3P]-labeled Sepharose-GST-LBD was
used to normalize for the amount of
Sepharose-GST-LBD used in each assay.
The binding of 3H-estradiol to the
Sepharose-GST-LBD fusion protein was
plotted as a function of the actual chemical
concentration used in the assay. The con-
centration that inhibits 50% (ICJ0) was cal-
culated as the chemical concentration
reducing the 3H-estradiol binding to 50%
ofmaximal binding. Data represent mean of
twvo independent experiments.
In Vitro Estrogen Receptor Binding
Assay (Laboratory 8) Based on Rabbit
Uterine Tissue. A classical ligand-binding
assay (LBA) employing dextran-coated
charcoal (DCC) to separate bound and free
ligands was used as described in detail in
EORTC (46) and Thorpe (47). Cytosol
prepared from rabbit uterine tissue was the
source of the ER-rich cytosol; rabbit
muscle was the source ofER-poor cytosol.
Fresh aliquots ofcytosols were thawed on
the day of analysis. Both cytosols were
diluted with assay buffer [PB: 10 mM
K2HPO4/KH2PO4, 1.5 mM K2EDTA, 10
mM monothioglycerol, 10 mM Na2MoO4
2H20, 10% glycerol (v/v); pH 7.51 to
approximately 3 mg cytosol protein/ml.
ER-rich cytosol was diluted with ER-poor
cytosol to achieve approximately 20 to 25%
maximal binding of 0.5 nM 3H-17J-estra-
diol (Amersham-Pharmacia-Bioteck).
Radioinert 17f3-estradiol was obtained from
Sigma Chemical.
The stock solutions of test compounds
were further diluted by ethanol for analysis
with PB. Aliquots of 10 pl test compounds
were incubated with 20 pl 3H-estradiol
(assay concentration 0.5 nM) and 50 pl
cytosol in microtiter plates for 18 to 20 hr
at 4°C. For control samples as well as maxi-
mal binding samples, 10 pl PB was added
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in lieu of test compound. To assess DCC
background counts, 50 pl = 0.3% bovine
serum albumin (BSA) in PB was added in
lieu of cytosol. To terminate the binding
reaction, 100 pl DCC slurry (0.5% acti-
vated charcoal [Sigma Chemical] and
0.005% dextran T70 [Amersham-Pharma-
cia-Bioteck] in PB) were added to each
sample and incubated with continuous
shaking for 15 min at 4°C. To separate
bound and free titrated estradiol, micro-
titer plates (Microwell, Nunc, Roskilde,
Denmark) were centrifuged for 10 min
(800xg) at 40C. Aliquots of 100 pl were
removed from each sample for scintillation
counting using Optiflour scintillation liq-
uid (Packard BioScience B.V, Groningen,
The Netherlands). Standards and control
samples were incubated in quadruplicate;
test compounds were incubated in dupli-
cate. The mean counts per minute in each
sample was calculated, background (DCC)
was subtracted, and percent of maximal
3H-17f-estradiol binding was calculated.
This value was plotted against the concen-
tration of test compound incubated
(expressed logarithmically). IC50 values
were used to compare binding affinities.
E-SCREENBased on Proliferation of
Human Breast Cancer Cells (MCF-7)
(Laboratories 1, 2, and3). This assay
introduced by Soto et al. (48) is based on
the estrogen-sensitive human breast cancer
cell line MCF-7. These cells require the
presence ofestrogen to grow as tumors in a
host. When MCF-7 cells are grown in acul-
ture medium supplemented with non-
estrogenic charcoal-dextran (CD)-stripped
human serum, proliferation is prevented.
When estrogen is added, the cells prolifer-
ate. This assay was performed in three dif-
ferent laboratories as described by Soto et al.
(48) (laboratory 2) or slightly modified as
described byVillalobos et al. (49) (laborato-
ries 1 and 3). Briefly, stock cultures of
MCF-7 BUS cells (passage 143 to 148),
were grown in Dulbecco's modification of
Eagle's medium (DME) supplemented with
5% fetal bovine serum (FBS) in an atmos-
phere of5% C02/95% air under saturating
humidity at 37°C. MCF-7 cells were
trypsinized and plated in 12-well plates
(Costar, Cambridge, MA) (laboratory 2) or
24-well plates (Limbro, McLean, VA) (labo-
ratories 1 and 3) at initial concentrations of
104 cells per well. Cells were allowed to
attach for 24 hr, then the seeding medium
(5% FBS in DME [laboratories 2 and 3] or
10% FBS in DME [laboratory 1]) was
replaced with the experimental medium
(5% CD-treated FBS [laboratory 2] or 10%
CD-treated human serum [laboratories 1
and 3] supplemented to phenol red-free
DME). CD-treated FBS and CD-treated
human serum were prepared as described by
Soto et al. (48) based on plasma supplied
from local blood banks. A range ofconcen-
trations ofthe test compounds was added to
this medium. All chemicals were diluted to
desired concentrations with DME immedi-
ately prior to use. The bioassay was termi-
nated on day 6 (late exponential phase) by
removing the media from the wells. In labo-
ratory 2 a cell-lysing solution (10% ethyl-
hexadecyl-dimethylammonium bromide)
(Eastman Kodak, Rochester, NY) in 0.5%
Triton X-100, 2 mM MgCl2, 12 mM
NaCl, 5 mM phosphate buffer, pH 7.4) was
added and the nuclei counted in a Model
ZM Coulter Counter Apparatus (Coulter
Electronics, Hialeah, FL). In laboratories 1
and 3 the cells were fixed and stained with
sulforhodamine-B (SRB) as described by
Brotons et al. (24) and Villalobos et al.
(49). Briefly, cells were treated with cold
10% trichloracetic acid (TCA) and incu-
bated at 40C for 30 min, then washed five
times with tap water and left to dry. TCA-
fixed cells were stained for 10 min with
0.4% (w/v) SRB dissolved in 1% acetic
acid. Wells were rinsed with 1% acetic acid
and air dried. Bound dye was solubilized
with 10 mM Tris base (pH 10.5) in a
shaker for 20 min. Finally, aliquots were
transferred to a 96-well plate and read in a
Titertek Multiscan plate reader (Titertek
Instruments, Inc., Huntsville, AL) at 492
nm (laboratory 3). In all three laboratories
the mean cell numbers from each experi-
ment were normalized to the steroid-free
control cultures to correct for differences
in the initial seeding density. Data repre-
sent the mean and are pools ofeither one
(laboratory 3), at least two (laboratory 1), or
at least three (laboratory 2) independent
experiments run in duplicate.
Transient Gene Expression Assay in
MCF-7Cells (Laboratory 7). MCF-7 cells
obtained from the Breast Cancer Task
Force Cell Culture Bank (Mason Research
Institute, Worcester, MA) (passage 298 to
310) were propagated in DME without
phenol red supplemented with 1% CD-
treated FBS, 64 pg/ml Gentamicin (Gara-
mycin, Schering-Plough, Madison, NJ),
2.5 mM glutamine, and 6 pg/liter, insulin
and transfected as described by Jorgensen
and Autrup (50,51) using a chimeric
reporter construct containing one ERE in
front of the thymidine kinase (tk) pro-
moter and the chloramphenicol acetyl-
transferase (CAT) gene pERE-tk-cat (52).
Upon transfection the cells were treated for
48 hr with solvent (0.1% ethanol [96%,
Merck, Darmstadt, Germany]), 10 nM
17,-estradiol (E 8875, Sigma Chemical),
or the test chemicals. The test chemicals
were tested at the highest nontoxic concen-
tration as deduced by a nonradioactive cell
proliferation/cytotoxicity assay (Promega,
Madison, WI). CAT activities were normal-
ized to transfection efficiency and protein
content as described by Jorgensen and
Autrup (50,51). Preliminary results indi-
cated that the use of CD-treated human
serum and CD-treated FBS give similar
results. Data are expressed as the mean ± SD
and are a pool ofat least nine samples from
three independent experiments.
Recombinant Yeast Estrogen Screen
UsingHumanEstrogen Receptor (Labora-
tories 4 and6). Yeast (Saccharomyces) sta-
bly transfected with the human estrogen
receptor (hER) gene and expression plas-
mids carrying an ERE and the reporter gene
lacZencoding the enzyme ,-galactosidase
was used and the assay performed as
described by Routledge and Sumpter (27).
The test chemicals were serially diluted in
absolute ethanol and 10 pl ofeach concen-
tration was transferred to a 96-well optically
flat-bottom microtiter plate (Titertek) and
allowed to evaporate to dryness on the assay
plate. Aliquots (200 pl) ofmedium contain-
ing recombinant yeast and the chromogenic
substrate chlorophenol red-P-D-galactopyra-
noside (Boehringer Mannheim, East Sussex,
UK) were then dispensed to each sample
well. Details of preparation of medium
components are discussed in Routledge and
Sumpter (27). Each plate contained at least
one row ofblanks (assay medium only) as
well as a standard curve for 17p-estradiol. In
laboratory 4, absorbance at 540 nm was
measured after 72-hr incubation using a
Titertek Multiscan MCC/340 plate reader
(Titertek). In laboratory 6, absorbance at
550 nm was measured after 72- and 93-hr
incubation using an Anthos 2010 plate
reader (Anthos Labtec Instruments,
Salzburg, Austria). In laboratory 6, testing
ofthe chemicals was repeated by adding the
chemicals directly to the medium instead of
evaporating them to dryness on the plate.
This repetition was to investigate if this
modification ofthe procedure had any effect
on the response obtained. Data represent
mean values from a single experiment
carried out in duplicate.
Recombinant Yeast Estrogen Screen
Using Human Estrogen Receptor and
Yeast Strain DY150 (Laboratory 10).
The yeast strain DY150 (MAT a ura 3-1 leu
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2-3 112 trp 1-1 his 3-11 15 ade 2-1 can
1-100) contains the yeast expression plas-
mid containing hER (YEPKB1) and the
estrogen-sensitive LacZ reporter plasmid
(2ERE-LacZ). This strain was grown
overnight at 30°C in synthetic medium,
supplemented with uracil and tryptophan,
in 2 ml cultures. The next day, 25 Pl of
the overnight culture was diluted into 975
pl fresh medium and grown overnight (18
hr) with 1 pl of the various stock solutions
of test chemicals corresponding to a final
concentration of 10 pM for the test chem-
icals and 10 nM for 17J3-estradiol. For 3-
galactosidase assays, the yeast cells were
collected by centrifugation, resuspended in
700 pl Z-buffer (60 mM Na2HPO4, 40
mM NaH2PO4, 10 mM KCl, 1 rmM
MgSO4, 35 mM 3-mercaptoethanol), and
permeabilized by the addition of 6 pl
CHCI3 and 4 pl 0.1% sodium dodecyl
sulfate (SDS) followed by vortexing for 25
sec. The reactions were equilibrated at
30°C for 10 min, then 160 pl o-nitro-
phenyl-D-galactopyranoside (ONPG) (4
mg/ml in Z-buffer) was added and the
reactions returned to 30°C for between 5
and 60 min. The reactions were termi-
nated by the addition of 400 pl 1 M
NaCO3, the cell debris was removed by
centrifugation, and the absorbance at 420
nM measured (A420). The growth of the
yeast strains was monitored by measuring
the absorbance at 600 nM (A600). Miller
units were determined using the following
formula: [A420/(A600 of 1/10 dilution of
cells xvolume of culture xlength of incu-
bation)] x 1000. The data represent mean
from three independent experiments with
determinations in triplicates.
Recombinant Yeast Estrogen Screen
Using Rainbow Trout Estrogen Receptor
(Laboratory 5). Saccharomyces cerevisiae
(strain BJ-ECZ) were stably transfected with
the rainbow trout estrogen receptor (rtER)
gene and an estrogen-responsive reporter
gene containing two ERE linked to the yeast
CYC1 promoter located upstream ofthe E.
coli gene for f-galactosidase (lacZ) as
described by Petit et al. (53). The cells were
grown in liquid culture in the absence (neg-
ative control) or presence (positive control)
of 10 nM 17p3-estradiol or test chemicals at
10 PM (1:1000 dilution of the stock solu-
tions directly in the yeast culture media) for
4 hr at 28°C. Cells were harvested, lysed,
the cell density was determined at 600 nm,
and the f3-galactosidase activity was mea-
sured at 420 nm using ONPG as substrate.
The data represent the mean from three
replicates in a single experiment.
Vitellogenin Production in Juvenile
Rainbow Trout in Vivo (Laboratory 9).
Juvenile rainbow trout (46 to 174 g), kept
in steel tanks at a photoperiod of 12 hr
light:12 hr dark, were randomly assorted
into experimental groups of six fish, anes-
thetized with 2-phenoxyethanol, and
injected ip with a single dose (adjusted to
1 ml/kg) ofthe compounds to be tested. The
compounds were dissolved in 50% ethanol,
99% ethanol, or peanut oil and injected in
the concentrations shown in Figure 2. A pre-
exposure blood sample was taken on day 0
and a final blood sample on day 9, and the
vitellogenin level in the plasma was mea-
sured by a direct sandwich enzyme-linked
immunosorbent assay (ELISA).
For the ELISA, purified vitellogenin
for antibody production and standards
was obtained from 1713-estradiol-treated
rainbow trout. Protein for immunization
of rabbits to raise polyclonal antibodies
against vitellogenin was obtained by
precipitation of trout serum with EDTA
and MgCl2 [modified from Wiley et al.
(54)]. Vitellogenin used for standards and
affinity columns was purified by gel
filtration (Sephacryl S300HR. Amersham-
Pharmacia-Bioteck) followed by anion
exchange chromatography (DEAE Seph-
acel, Amersham-Pharmacia-Bioteck).
Antibodies against vitellogenin were
obtained from ammonium sulfate-pre-
cipitated rabbit antiserum after affinity
chromatography on a CNBr-activated
Sepharose 4B column (Amersham-
Pharmacia-Bioteck) coupled with rainbow
trout vitellogenin. The specificity of the
antibodies was verified by Western blot-
ting of trout plasma after native- and
SDS-polyacrylamide gel electrophoresis
(PAGE). The antibodies were used for
constructing a direct sandwich ELISA.
Microtiter plates were coated with specific
antibodies and blocked with BSA (3%).
Vitellogenin standards or samples were
added followed by incubation with horse-
radish peroxidase-coupled antibodies. The
color development after adding enzyme
substrate (OPD) was monitored at 490
and 650 nm. The resulting assay had a lin-
ear range of 5 to 50 ng/ml and a detection
limit of 500 ng/ml serum. The concentra-
tion ofvitellogenin in serum at day 0 and
day 9 was measured in samples from each
fish and the difference in vitellogenin cal-
culated. In cases where the vitellogenin
levels were below the detection limit ofthe
assay, the concentration of the sample was
set to the detection limit of 0.5 pg/ml.
The data express the mean increase in
serum vitellogenin for the six fish in the
experimental group.
Results
All test chemicals were tested in a blind
fashion, and the identities of the chemicals
were not revealed until all results had been
reported to the project coordinator. All
laboratories also tested their own positive
control (17j-estradiol) and a hormonle-
free control. After reporting, all data were
recalculated in reference to the positive
control from the test panel to ensure com-
parability of the results. Some laboratories
examined a range of concentrations; other
laboratories chose to use only a single coIn-
centration of the test chemicals in accor-
dance with their rouitine procedure for
short-term tests.
For each in vitro assay, the response to
a chemical was judged as fully estrogenic if
the response was > 75%, partially estrogenic
ifthe response was 25 to 75%, weakly estro-
genic if the response was 10 to 25%, and
negative if the response was below 1O0% of
the response induced by 17f3-estradiol. In
the in vivo assay in rainbow trout, the
increase in vitellogenin production was steep
upon stimulation with the three potent
estrogens, 17p-estradiol, 17oc-ethynyl estra-
diol, and DES. Because the maximal
response of the individual test compounds
in this assay is unknown and different single
doses ofthe chemicals were used for testing,
it is not possible to compare the responses
directly or to judge the potencies of the
chemicals as in the in vitroassays.
17p3-Estradiol and 17(x-ethynyl estradiol
exhibited strong estrogenic activity in all
assays (Figures 2-7 and Table 3). DES
induced a partial estrogenic response in the
reporter gene expression assay in MCF-7
cells and in the DY150 yeast assay but
induced a full estrogenic response in all
other assays. The relative binding affinities
(RBA) of 17cx-ethynyl estradiol and DES
were higher than that for 17f-estradiol in
both binding assays. In one laboratory using
the MCF-7 cell proliferation assay, the
response curve for 17f-estradiol showed a
decrease at concentrations above 0.0001
pM, indicating a toxic response. The known
cytotoxic compound colchicine induced no
estrogenic response in any of the assays but
was clearly toxic in most assays.
The antiestrogens tamoxifen and ICI
182.780 bind strongly to the recombinant
hER from MCF-7 cells with affinities
similar to 17f-estradiol. ICI 182.780 also
binds strongly to ER from rabbit uterus,
whereas the binding affinity of tamoxifen
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Table3. Relative binding affinities ofthetestchemicals inthe two binding assays.
IC50, M RBAa IC50, M RBAa
recombinant recombinant rabbit rabbit
Testcompound hER hER uterus ER uterus ER
17(1-Estradiol 1.45x10- 1 2.0x10-11 1
17[-Ethynyl estradiol 6.7x10-10 2.2 2.0x10-12 10
DES 2.5x10-'0 5.8 7.0x10-15 2857
Tamoxifen 2.6x10-9 0.6 1.2x107 1.7x104
ICI 182.780 3.6x109 0.4 4.0x10-12 5
Testosterone >2x10 - >1.0x10 -
BisphenolA 1.1x104 1.3x104 1.6x104 1.3x105
Bisphenol Adimethacrylate >2x104 - 4.3x10 4.7x106
4-r-OP 4x104 3.6x104 >1.0x10- -
4-n-NP 4.3x104 3.4x104 1.8x104 1.1 x10-5
NP12E0 5.7x 10- 2.5x10- >1.0x10-5 -
BBP 1.2x104 1.2x104 >1.0x105 -
DBP >2x104 - >1.0x105 -
Methoxychlor >2x104 - 6.5x104 3.1 x107
o,p'-DDT 5x10-7 2.9x103 3.4x10 5.9x10
pJp-DDE 1.6x10C 9.1 x10 >1.0x10-5 -
Endosulfan 1.3x10- 1.2x104 >1.0x105 -
Chlormequatchloride 5.6x10-5 2.6x10 >1.0x10-5 -
Colchicine >2x10-4 - >1.0x10 -
Ethanol NC - NC -
Abbreviations: NC, no competition forthe binding of 173-estradiol. RBA, relative binding affinities. 'RBAwas cal-
culated as the ratio between the binding affinity (IC50) of 17fi-estradiol and the binding affinity of the test com-
pound to the ER inthetwobinding assays.
Ef
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Tetcompounds
Figure2 Increase invitellogenin production injuvenile rainbow trout9daysaftera single intraperitoneal injectionof
the testcompounds atthedoses indicated. The increase invitellogenin production was calculated asthe serum con-
centration at day 9 minus the serum concentration at day 0. A, 17-estradiol (0.5 mg/kg in 50% ethanol); B, 17a-
Ethynyl estradiol (5mg/kg in peanutoil); C, DES(5mg/kg in50%ethanol); 0,tamoxifen(50mg/kg in 99% ethanol); E,
ICI 182.780(50 mg/kg in 99% ethanol); F, testosterone (not investigated); G, bisphenol A(50 mg/kg in 50% ethanol);
H, bisphenol Adimethacrylate (50 mg/kg in peanutoil); I,4-n-octylphenol (50mg/kg in peanutoil); J. 4-nnonylphenol
(50 mg/kg in peanut oil); K, nonylphenol dodecylethoxylate (50 mg/kg in 50% ethanol); L, benzylbutylphthalate (500
mg/kg in peanutoil); M,dibutylphthalate (500mg/kg in peanutoil); N,methoxychlor(100 mg/kg in peanutoil); 0,oJp-
0DT(50 mg/kg in peanutoil); P.p4p-DDE(100mg/kg in peanutoil); a endosulfan(5mg/kg in peanutoil); R. chlorme-
quatchloride(250mg/kg in peanutoil); S,colchicine(1 mg/kg in peanutoil); T,ethanol(1 mI/kg).
for this receptor was only 1/6000th the
binding affinity of 17f-estradiol (Table 3).
In the proliferation assay in MCF-7 cells,
tamoxifen induced an estrogenic response
in one laboratory (77% of the maximum
response induced by 17[1-estradiol), a weak
response in another laboratory (21% ofthe
17,-estradiol response), and no response in
the third laboratory using this assay. ICI
182.780 induced no estrogenic activity in
any ofthe three laboratories using the E-
SCREEN assay (Figure 3). Reporter gene
expression in MCF-7 cells was below the
hormone-free control for both antiestrogens
(Figure 5). In yeast, ICI 182.780 exhibited
filll estrogenic activity in all assays (Figures
4,7) except one (laboratory 10) using the
yeast strain DY150 (Figure 5). Tamoxifen
responded as a partial estrogenic agonist in
all the yeast assays, though only weakly in
yeast DY150. In Saccharomyces expressing
the hER, a maximal response was observed
at tamoxifen concentrations just below 1
pM, whereas the response at higher con-
centrations was decreased because oftoxic-
ity (Figure 4). Tamoxifen, but not ICI
182.780, induced vitellogenin production
in rainbow trout. However, the level of
vitellogenin produced was only 0.04% of
the level induced by 17restradiol at 1% of
thedose oftamoxifen (Figure 2).
Although no ER binding was registered
in the bindingassays (Table 3), testosterone
exhibited full estrogenic activity in the
proliferation as well as the reporter gene
expression assays in MCF-7 cells (Figures
3,5). Maximal proliferation was induced at
1/1000th to 1/10000th the 17p-estradiol
concentration inducing maximal response.
Testosterone induced a weak reporter gene
activity in Saccharomyces expressing the
hER but only at concentrations above 10
PM (Figure 4), while no response was
induced in any of the other yeast assays
(Figures 6,7) in which only one con-
centration of 10 pM testosterone was
tested. Testosterone was not investigated in
the vitellogenin assay in rainbow trout
because we were unable to obtain sufficient
quantities ofthe chemical because oflegal
restrictions forimportingsteroid hormones.
In the binding assay using recombinant
hER, o,p'-DDT was the most effective of
the environmental chemicals tested in
reducing the binding of[3H]17p-estradiol;
binding affinities were 1/350th of the
binding affinity of 17,B-estradiol (Table 3).
The binding affinity ofp,p'-DDE was
considerably lower, i.e., approximately
1:10,000 compared to the binding affinity
of17-aestradiol. Also, 4-n-OP and 4-n-NP
had similar affinities for the ERofapproxi-
mately 1:3000 that of 17p-estradiol,
whereas the ratio for bisphenol A, BBP,
and endosulfan was about 1:8000. Both
NP12EO and chlormequat chloride only
barely reduced the binding of [3H]17P-
estradiol to hER with binding affinities of
approximately 1/40,000th ofthe binding
affinity of 17p-estradiol. Bisphenol A
dimethacrylate, DBP, methoxychlor, and
colchicine all had IC50 values above the
limitof200 pM fornonspecific binding.
The binding affinities ofthe environ-
mental chemicals for the ER from rabbit
uterus were in general lower than for the
hER from MCF-7 cells, and only five
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Figure 3. Effects of the test chemicals on proliferation of MCF-7 cells expressed as fold increase in cell number above hormone-free control as a
function of the log concentration of the test compound. The test compounds were added to cells growing in medium supplemented with 10%
CD-treated human serum (laboratory 1 and 3) or 5% CD-treated FBS (laboratory 2) and incubated for 6 days. Laboratory 1 (m), laboratory 2 (0), and
laboratory 3 (A). (Continued on nextpage)
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Figure 5. Transient reporter gene expression in MCF-7 cells. The results are expressed as the ratio between the
activity of CAT in cells exposed to test compounds (concentrations as stated below) and cells exposed to hormone-
free solvent after 48-hr incubation. A, 17p-Estradiol (0.01 pM), B, 17cx-Ethynyl estradiol (1.1 1 pM); C, DES (0.63
pM); D, tamoxifen (2.5 pM), E, ICI 182.780 (2.5 pM); F, testosterone (10 pM); G, bisphenol A (10 pM); H, bisphenol
A dimethacrylate (10 pM), I, 4-n-octylphenol (2.5 pM), J, 4-n-nonylphenol (2.5 pM); K, nonylphenol dodecylethoxy-
late (0.63 pM); L, benzylbutylphthalate (5 pM); M, dibutylphthalate (10 pM); N, methoxychlor (2.5 pM); 0, op'-DDT
(2.5 pM), P, p,p'-DDE (10 pM), 0, endosulfan (2.5 pM); R, chlormequat chloride (2.5 pM), T, ethanol (0.1%).
'.::
Figure 6. P-Galactosidase activity in yeast (DY150) expressing the hER after 18-hr incubation with the test com-
pounds. The final concentration tested was 10 nM for 17p-estradiol and 10 pM for all other test compounds. A,
17p-estradiol, B, 17cx-ethynylestradiol, C, DES, D, tamoxifen; E, ICI 182.780, F, testosterone, G, bisphenol A; H,
bisphenol A dimethacrylate, /, 4-n-octylphenol; J, 4-n-nonylphenol, K, nonylphenol dodecylethoxylate; L, benzyl-
butylphthalate; M, dibutylphthalate, N, methoxychlor, 0, o,p'-DDT, P, p,p'-DDE; 0, endosulfan, R, chlormequat
chloride; T, ethanol (0.1%).
chemicals had IC50 values below 1000 pM,
i.c., the limit for nonspecific binding in this
assay (Table 3). Of the environmental
chemicals, bisphenol A and 4-n-NP had the
highest binding affinities of 1:8000 and
1:90,000, respectively, compared to the
binding affinity of 17f-estradiol, whereas
o,p'-DDT showed an affinity ratio of
1:170,000. Bisphenol A dimethacrylate and
methoxychlor also bind to the ER, although
with low affinity. No binding of these two
compounds was detected in the other
binding assay based on recombinant hER.
Among the environmental chemicals,
bisphenol A, bisphenol A dimethacrylate,
BBP, o,p'-DDT, and chlormequat chloride
reacted as full agonists in the MCF-7 cell
proliferation assays by inducing cell prolif-
eration to an extent (75 to 100%) similar
to that caused by 0.1 nM 17p-estradiol in
at least two of the three laboratories using
this assay (Figure 4). Bisphenol A and
bisphenol A dimethacrylate were the most
potent chemicals because they induced
a full estrogenic response at 1 pM or
1/10,000th of the concentration needed of
17'-estradiol to induce maximal response.
Although 4-n-OP and 4-n-NP had higher
binding affinities than bisphenol A and
bisphenol A dimethacrylate in the recom-
binant hER binding assay, these two com-
pounds reacted only as partial agonists in
the E-SCREEN assay, inducing maximal
proliferation of 70 and 50% 17r3-estradiol,
respectively, at 10 pM. NP12EO did not
induce proliferation ofMCF-7 cells in any
of the laboratories. o,p'-DDT induced a
full agonistic response at concentrations of
2 and 10 pM in two of the laboratories
using this assay and a maximal response of
46% of 17p-estradiol at 1 pM in the third
laboratory. p,p'-DDE reacted as a partial
agonist in two laboratories and as a full
agonist in one laboratory, inducing maxi-
mal responses of 30, 60, and 90% of 17p-
estradiol at 10 or 100 pM in the three
laboratories, respectively. Endosulfan
reacted as a partial agonist in two laborato-
ries and as a weak agonist in one labora-
tory, inducing maximal responses of 60,
33, or 21% of17p-estradiol at 5 to 10 pM.
At higher concentrations the cell number
was lower than in control cells, indicating a
toxic response. Chlormequat chloride
reacted as a full agonist in two laboratories,
inducing proliferations of approximately
80% of17p-estradiol at concentrations of5
or 10 pM, and as a partial agonist in the
third laboratory, inducing maximal prolif-
erative response of 50% of 17J-estradiol at
1 pM and a lower response at higher con-
centrations. Methoxychlor reacted as a par-
tial agonist, inducing maximal proliferative
responses of approximately 40 to 60% of
17r-estradiol at 5, 10, or 100 pM in the
three laboratories. DBP induced a response
of 30 to 40% of 17p-estradiol in all three
laboratories at relatively high concen-
trations (50 to 100 pM), whereas BBP
induced a considerably higher response of
45% at 100 PM, 83% at 10 pM, or 100%
at 10 pM of 17p-estradiol in the three
laboratories, respectively.
When the environmental chemicals were
tested for their ability to stimulate the tran-
scriptional activity of the ER in MCF-7
cells, the strongest response was observed for
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Figure 7. j-Galactosidase activity in yeast(Saccharomyces) expressing the rtER after 4-hr incubation with the test
compounds at 28°C. The final concentration tested was 10 nM for 17p-estradiol and 10 pM for all other test com-
pounds. A, 17,B-estradiol; B, 17a-ethynyl estradiol; C, DES; D, tamoxifen; E, ICI 182.780; F, testosterone; G, bisphe-
nol A; H, bisphenol A dimethacrylate; /, 4-n-octylphenol; J, 4-n-nonylphenol; K, nonylphenol dodecylethoxylate; L,
benzylbutylphthalate; M, dibutylphthalate; N, methoxychlor; 0, o,p-DDT; P, p,j-DDE; 0, endosulfan; R, chlorme-
quat chloride; T, ethanol (0.1%).
o,p'-DDT, p,p'-DDE, and chlormequat
chloride, which at concentrations of2.5, 10,
and 2.5 pM, respectively, induced increases
in CAT activity 2.5 to 3 times higher than
the hormone-free control level (Figure 5) or
70 to 75% of the response induced by 10
nM 17p-estradiol. Bisphenol A (10 pM),
bisphenol Adimethacrylate (10 pM), and 4-
n-OP (2.5 pM) reacted as partial estrogen
agonists by increasing CAT activity 2.3-,
2.0-, or 2.2-fold above control (or 50, 38, or
46% of 10 nM 17p-estradiol), respectively.
The response to 4-n-NP (2.5 pM) was con-
siderably weaker; it was only 1.2-fold above
control or 7% of 10 nM 17i-estradiol. Also
methoxychlor (2.5 pM), BBP (5 pM), and
DBP (10 pM) induced only weak responses
of 1.3- to 1.5-fold above controls (11 to 19
% of 10 nM 17p-estradiol). NPI2EO,
endosulfan, and colchicine did not induce
CAT activity above the control level. As
expected, colchicine was toxic to the cells at
lowconcentrations of0.01 pM andabove.
The ability of the test compounds to
induce reporter gene activity in yeast
(Saccharomyces) expressing the hER was
investigated by two laboratories. The
response to all test chemicals, including
17p-estradiol, in one ofthese laboratories
was in general slightly higher than the
corresponding response in the other labora-
tory. The concentration of 17p-estradiol
that induced maximal activity was 0.001 or
0.005 pM in the two laboratories, respec-
tively (Figure 4). If 17,-estradiol was added
directly to the medium, a maximum response
was reached at a lower concentration than
when 17p-estradiol was evaporated to
dryness on the assay plate (Figure 8). A
similar effect was observed for DES and
17a-ethynyl estradiol (data not shown).
At 10 or 60 pM, bisphenol A increased
reporter gene activity in yeast to a level
similar to that of 17,-estradiol (Figure 4).
Bisphenol A dimethacrylate induced a
weak or partial estrogenic response (20 or
33% of 17J-estradiol) at 100 to 200 pM.
Besides bisphenol A, only chlormequat
chloride induced a full estrogenic response
in both laboratories. Methoxychlor reacted
as a full agonist, inducing P-galactosidase
activity to 84% of 17IB-estradiol at 170 pM
in one laboratory and as a partial agonist,
inducing a response of60% of17p-estradiol
at 500 pM in the other laboratory. o,p'-
DDT induced a partial agonistic response of
approximately 30% of17p-estradiol at 500
pM and a flat dose-response curve in both
laboratories, whereas p,p'-DDE was inac-
tive, in both laboratories. Ofthe two phtha-
lates, BBP induced a weak response of7 to
14% that of 17p-estradiol at 170 to 250
pM in both laboratories and DBP was inac-
tive, at the concentrations tested. Both 4-n-
OP and 4-n-NP were toxic to the yeast. The
toxic effect was pronounced in one of the
laboratories in which the yeast was killed at
concentrations above 10 pM, thus possibly
obscuring an estrogenic effect. In the other
laboratory a partial estrogenic response was
induced by 4-n-NP showing a maximum of
40% ofthe 17p-estradiol response at 20 pM
4-n-NP. Endosulfan and NP12EO did not
induce j-galactosidase activity above control
levels in either ofthe two laboratories when
the chemicals were evaporated on the assay
plate. In laboratory 6 all test chemicals
were retested by adding the chemicals
directly to the medium instead ofevaporat-
ing the test compound before adding the
medium and yeast. This procedure led to a
higher response for some ofthe test chemi-
cals: bisphenol A dimethacrylate, o,p'-DDT,
and BBP (Figure 8). NPl2EO, which did
not induce activity when the chemicals were
evaporated to dryness on the assay plate,
now induced a full agonistic response (85%
of 17,B-estradiol) at 380 pM when the
chemical was added directly to the medium.
In addition, 4-n-OP and 4-n-NP induced a
more pronounced toxic response when the
chemicals were added directly to the
medium. These results indicate that at least
some chemicals may adhere to the surface of
the assay plates when the test compounds
are evaporated to dryness on the plate before
yeast and medium are added, thus leading
to lower availability ofthe test compound.
The incubation time used in both
laboratories was 72 hr for all test substances.
However, incubation time has a pro-
nounced effect on the level ofP-galactosi-
dase activity induced by several chemicals.
In laboratory 6 the activity induced for all
test chemicals was determined after both 72
and 93 hr. After 93 hr,P-galactosidase activ-
ities induced by 4-n-OP, 4-n-NP, bisphenol
A dimethacrylate, and o,p'-DDT were
considerably higher than after 72 hr (data
not shown).
In the yeast strain DY150, a single
concentration of 10 pM ofeach compound
(10 nM for 17,-estradiol) was tested.
Bisphenol A induced a weak estrogenic
response after 18 hr incubation; the other
environmental chemicals were inactive. The
0-galactosidase activity after addition of
o,p'-DDT, p,p'-DDE, and endosulfan was
even below control, thus possibly indicating
a toxic response to the high concentrations
used in this assay (Figure 6).
Also in the yeast system expressing the
rtER, only a single concentration of 10 pM
ofeach compound (10 nM for 17p-estra-
diol) was tested. The yeast was incubated
with the test chemicals for 4 hr before the
activity of 3-galactosidase activity was mea-
sured. Among the environmental chemi-
cals, 4-n-NP, 4-n-OP, and bisphenol A
reacted as full agonists in this assay; o,p'-
DDT and methoxychlor were partial
agonists, inducing responses approximately
halfthat of 10 nM 17p-estradiol. BBP and
endosulfan were weak agonists, inducing
responses of 18 and 16% of 17,B-estradiol;
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the remaining compounds induced a
response similar to the hormone-free con-
trol (Figure 7). Cell density was not
affected by any of the test compounds,
indicating the absence of cytotoxic effects
in this assay.
Vitellogenin is a classic estrogen-indu-
cible protein synthesized in the liver of
oviparous vertebrates under the control of
estrogen. It is normally synthesized in
females and the production increases
markedly in serum during oocyte develop-
ment. The vitellogenin gene is present but
usually not expressed in males or juveniles.
However, exposure to estrogens, estrogen
mimics, or aromatase inducers can elicit
vitellogenin synthesis in males (4). Only
three of the environmental chemicals tested
induced increased vitellogenin production
in juvenile rainbow trout using the present
test conditions and concentrations of test
substances (Figure 2). The doses were
selected to be approximately one-tenth of
the median lethal dose values reported in
mammals or fish if the data were available.
The strongest response was induced by
bisphenol A administered in a dose of 50
mg/kg. BBP (500 mg/kg) and bisphenol A
dimethacrylate (50 mg/kg) induced a weak
increase in vitellogenin production. 4-n-NP
(50 mg/kg) induced a low increase in vitel-
logenin production of only 0.003% of the
response induced by 1713-estradiol (0.5
mg/kg); the vitellogenin production was
enhanced only in one ofsix fish and, consid-
ering the standard deviation, the response
could not be regarded as different from
those of untreated fish. Chlormequat chlo-
ride at the dose used (250 mg/kg) killed all
six fish in the group within a few minutes;
therefore, the ability of this chemical to
induce vitellogenin synthesis could not be
evaluated within the limits ofthis study.
In some of the assays (E-SCREEN,
transient reporter gene expression in MCF-7
cells, and the recombinant yeast assay
expressing the hER) an estrogenic response
was induced by the ethanol used as solvent
control in the test panel (Figures 3-5). In
the E-SCREEN the highest dilution of
ethanol that induced a response above
hormone-free controls was 10,000- to
100,000-fold (or 0.01 to 0.001% ethanol),
corresponding to a concentration of 0.1 to
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1 pM ofthe other test chemicals. A maxi-
mal response was induced at 500- to
1000-fold dilutions, corresponding to 10
to 20 pM ofthe test compounds. In yeast a
response was induced at dilutions lower
than 100-fold, corresponding to concentra-
tions higher than 100 pM ofthe test com-
pounds or 1% ethanol. In the transient
reporter gene assay in MCF-7 cells, 0.1%
ethanol induced a response of27% ofthe
response seen with 10 nM 173-estradiol.
The ethanol used was analyzed by mass
spectrometry, and no contaminants were
detected even after the ethanol was concen-
trated 100-fold. However, the detection
limit ofmass spectrometry might not be
low enough to detect trace amounts of
strong estrogens. When samples ofethanol
ofthe same brand but from a previously
unopened bottle were retested, no response
was induced in the two MCF-7 cell assays.
In addition, testing for memory effect or
contamination from test vials, pipette tips,
and gloves using this ethanol showed no
sign ofestrogenicity.
Discussion
This comparison study in 10 different
laboratories compares results obtained after
blind testing 20 compounds by a range of
short-term assays for estrogenicity. The
testing was successfully performed, and the
results allow comparison ofthe sensitivity
ofthe assays for different types ofchemicals
and the reproducibility between laborato-
ries ofthe E-SCREEN and the yeast estro-
gen assay. We will review the results in
relation to previous findings for the test
chemicals. On this basis we will then dis-
cuss the validity and usefulness ofthe test
methods used.
As expected, 17p-estradiol, 17ac-ethynyl
estradiol, and DES induced an estrogenic
responses in all test systems. The binding
affinity ofDES for ER was higher than the
binding affinity of 17,-estradiol, and the
potency ofDES in the MCF-7 proliferation
assay was approximately one-tenth that for
17p3-estradiol. These results are in good
agreement with those in earlier reports (48).
The binding affinities ofthe test chemi-
cals varied considerably between the two
binding assays (Table 3). Thebinding affin-
ity oftamoxifen to recombinant hER from
MCF-7 cells was similar to that of 17I-
estradiol, whereas the binding affinity of
tamoxifen to ER from rabbit uterus was
only 1/6000th of the binding affinity of
17,-estradiol. Only three ofthe environ-
mental chemicals had binding affinities
above the level ofnonspecific binding in
both binding assays. These chemicals were
bisphenol A, 4-n-NP, and o,p'-DDT.
Kuiper et al. (55) show that the ER exists
as two different subtypes: ER-a and ER-p.
Differences in relative ligand binding affinity
and tissue distribution ofthe two ER sub-
types could possibly explain some of the
discrepancies in binding affinities observed
in the two binding assays. Another possible
explanation is that the recombinant hER
binding assay is based on isolated ER with-
out any other cellular constituents, whereas
the LBA based on rabbit uterus includes
cytosol-containing cellular proteins with
possible metabolizing capacity. The exis-
tence ofmetabolizing enzymes is supported
by the ability ofmethoxychlor to inhibit
the binding of3H-17p-estradiol to the ER
in this assay because only the demethylated
metabolite, not methoxychlor itself, binds
to the ER (40,56).
The E-SCREEN assay was performed
in three different laboratories. In one labo-
ratory the MCF-7 cell proliferation was
determined by direct cell counting; a stain-
ing technique was used in the other two
laboratories. For several of the test com-
pounds, good agreement was observed
among the results obtained in the three lab-
oratories. However, tamoxifen, testos-
terone, BBP, o,p'-DDT, p,p'-DDE, and
chlormequat chloride showed discrepant
responses in the three laboratories (Figure
3). ER expression in MCF-7 cells is modi-
fied by factors such as growth rate and cell
density (57), and different MCF-7 stocks
may exhibit different responses to estradiol
and chemicals with estrogenic activity (49).
However, cells from the same MCF-7
stock (BUS) were used in all three labora-
tories. Binding proteins (SHBG and
albumin) seem to be present in charcoal-
stripped serum and approximately 85% of
estradiol is bound to plasma proteins in
the E-SCREEN assay when 10% CD-
treated serum was added to the medium
(58). In this study CD-treated serum was
prepared in the individual laboratories,
and minor differences in protein content
cannot be excluded. In two of the labora-
tories, 10% CD-treated serum-and in
one laboratory 5% CD-treated serum-
was added to the test medium. Because the
proliferation was induced to similar
degrees by 17p-estradiol in the three labo-
ratories, this difference in procedure
apparently does not affect the results.
It has been discussed whether cell
proliferation or activation ofreporter genes
is the most reliable end point to estimate
estrogenic potency (5). In this study, the
proliferation assay (E-SCREEN) and the
reporter gene expression assay in MCF-7
cells showed good agreement regarding
chemicals identified as estrogenic or non-
estrogenic, although the dassification as fiull,
partial, or weak estrogens varied somewhat
between the assays (Figures 3 and 5). In the
reporter gene expression assay, the test com-
pounds were examined at only one concen-
tration after ensuring that it was the highest
nontoxic concentration to the cells. Hence,
the response obtained will probably be dose
to the maximal estrogenic response ofthe
test chemical in this assay. The responses
calculated as percentages ofthe response
induced by 170-estradiol were in general
lower in the reporter gene expression assay
than in the proliferation assay; therefore
most chemicals identified as full or partial
estrogenic agonists in the proliferation assay
were judged as partial or weak agonists,
respectively, in the reporter gene assay. Only
one ofthe environmental chemicals (bisphe-
nol A) induced a full estrogenic response in
both assays. Endosulfan induced no reporter
gene activation above the hormone-free
control at 25 pM but a weak proliferation
response at 5 to 10 pM. Differences in sen-
sitivity to estrogens between different MCF-
7 cell stocks (49) may contribute to
deviations in the response pattern between
the two assay systems because different
stocks ofMCF-7 cellswere used.
The assay based on hER expression in
Saccharomyces was used in two different
laboratories. Their results were similar,
although one laboratory consistently
tended to obtain slightly higher results
than the other laboratory (Figure 4).
However, for most of the chemicals the
two laboratories agreed on classification as
strong, partial, or weak estrogens, or as
nonestrogenic. The yeast assay is not
always capable ofdiscriminating between
antagonists and agonists, as the pure antie-
strogen ICI 182.780 and the partial antie-
strogen tamoxifen both induced increased
P-galactosidase activity. This finding is in
agreement with earlier observations (59)
and thus indicates that both tamoxifen and
ICI 182.780 bound to ER are able to
induce expression of an ERE-linked
reporter gene in yeast. The nature ofago-
nist-receptor versus antagonist-receptor
interaction and the resulting altered tran-
scriptional activity are poorly understood.
Metzger et al. (60) reported that the
regions of hER that are important for
activation ofthe transcription ofestrogen-
sensitive reporter genes in yeast and
mammalian cells may be different. These
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regions are not believed to be involved in
the binding of estrogens to the receptor. By
comparing results obtained in yeast with
results obtained in, e.g., MCF-7 cells, more
information may be revealed regarding the
mechanisms involved in antagonistic versus
agonistic responses.
The stimulation of proliferation and
transcriptional activity in MCF-7 cells by
testosterone is in agreement with earlier
findings and is thought to be due to con-
version of testosterone to estradiol cat-
alyzed by a high activity of aromatase
present in these cells (61,62). In the differ-
ent yeast strains, testosterone induced no
response or a very weak response-a finding
that is in accordance with earlier observa-
tions (15,27) and the notion that yeast has
no aromatase activity.
Among the environmental chemicals
tested, bisphenol A induced the highest
estrogenic response in all the assays, albeit
the relative binding affinity for ER and the
relative potency in the E-SCREEN and in
the Saccharomyces hER assays were all a
factor of 10,000 to 100,000 less than 173-
estradiol (Table 4). These results are in
accordance with earlier reports on the bind-
ing affinity of bisphenol A for the ER
(16,26) and the induced proliferation in
MCF-7 cells (26). Low doses of this chem-
ical may induce biologic responses in vivo.
When bisphenol A was fed to pregnant
mice, doses of only 2 and 20 ,ug/kg/day
significantly increased the adult prostate
weight of the males exposed in utero (16).
In the present study a single dose of 50
mg/kg induced a marked increase in vitel-
logenin production in rainbow trout
(Figure 2). Concentrations of bisphenol A
capable ofinducing proliferation in MCF-7
cells have been detected in the liquid phase
of preserved vegetables from lacquer-coated
cans and in water autoclaved in the cans
(24). In addition bisphenol A and bisphe-
nol A dimethacrylate have been detected in
saliva collected during a 1-hr period after
treatment with a dental sealant based on
bisphenol A diglycidylether methacrylate
(26). In Olea et al. (26) as well as in our
study, bisphenol A dimethacrylate induced
cell proliferation in MCF-7 cells with a
potency similar to bisphenol A (Table 4).
Also in Saccharomyces containing the hER,
a weak positive response was induced by
bisphenol A dimethacrylate (Figure 4).
However, the binding of bisphenol A
dimethacrylate to recombinant hER was
below the limit for nonspecific binding,
whereas a weak binding to the ER from
rabbit uterus was observed (Table 3). Olea
et al. (26) also reported a low binding
affinity of bisphenol A dimethacrylate for
cytosol ER. Despite the low binding affin-
ity for the ER, bisphenol A dimethacrylate
induced vitellogenin production in rainbow
trout and a strong estrogenic response in
MCF-7 cells. This indicates that bisphenol
A dimethacrylate might be metabolized to
bisphenol A in these test systems and prob-
ably also in the LBA based on cytosol from
rabbit uterus.
Alkylphenol polyethoxylates (APEs) are
nonionic surfactants produced worldwide
at > 300,000 tons annually (4).The alkyl
group is typically a branched nonyl, octyl,
or dodecyl chain. Nonylphenol ethoxylates
(NPEs) are the most commonly used
APEs, constituting about 80% of the pro-
duction. The primary biodegradation of
NPEs is the hydrolytic removal ofethoxy-
late groups. This step is relatively rapid and
results in degradation intermediates NP,
NP monoethoxylate, and NP diethoxylate,
all ofwhich are rather lipophilic and stable
in the environment (18). For NP12EO,
weak binding to the recombinant hER was
detected, but the IC50 was near the range
of nonspecific binding. No estrogenic
response was induced in any of the other
assays performed in this study except in the
yeast assay when the chemical was added to
the medium instead of evaporating it on
the test plate (Figure 8). The reason for
this lack of response needs further clarifica-
tion. Although NP12EO seems rather
toxic to all the cell types even at low con-
centrations, the compound itself does not
seem to have any estrogenic potential and
the cell types used in the assays included
are probably not capable of metabolizing
NP12EO to NP or NP diethoxylate (31).
Table 4. Relative potencies of the test compounds in the E-SCREEN and the yeast assay based on Saccharomyces expressing the hER.
EC50aE-SCREEN Rpb E-SCREEN EC50ayeast assay Rpbyeast assay
Test compound Lab 1 Lab 2 Lab 3 Lab 1 Lab 2 Lab3 Lab4 Lab6 Lab 4 Lab6
171-Estradiol 6x10-13 7x10-12 1x10-13 1 1 1 8x10-1 2x10-10 1 1
17,B-Ethynyl estradiol NE 8x10-12 3x10-12 - 0.9 003 5x10-10 6x10-11 1.6 3.3
DES NE 8x 101 NE 0.05 3 x 10-9 5x 10-10 0.2 0.4
Tamoxifen R<50 R<50 4x10 12 003 R<50 3x10 - 7x10- ICI 182.780 R<50 R<50 R<50 - - - 2x10-5 8x104 4x10-5 3x10-5
Testosterone 2x 10-7 6x 10-7 R<50 3x106 1 x 10-5 - R<50 R <50 - -
BisphenolA 2x10-7 7x10-7 2x10-7 3x10 1x10-5 5x10-7 1x10-5 5x106 8x10-5 4x10-5
Bisphenol A 9x104 3x10-7 2x10-9 7x104 2x10-5 5x10-5 R<50 R<50
dimethacrylate
4-n-OP 4x104 5x104 5x104 2x10-7 1 x104 2x104 R<50 R<50 - -
4-n-NP 8x104 1 x10-5 NE 8x104 7x10-7 R<50 R<50 - -
NP12EO R<50 R<50 R<50 - - - R<50 R<50 - -
BBP R<50 5x104 1xl106 _ 1X104 1 x10-7 R<50 R<50 - -
DBP R<50 R<50 R<50 - - - R<50 R<50 - -
Methoxychlor 4x104 5x104 R<50 2x10-7 1 x104 - 4x10 3x10-5 2x104 7x104 o,p'-DDT 1 x104 5x10-7 2x104 6x10-7 1 x10-5 5x104 R<50 R<50 - -
p,p'-DDE 2x104 3x10-5 7x10-5 1 x10-7 2x10-7 1 x10-9 R<50 R<50
Endosulfan 6x104 R<50 R<50 9x10-7 - - R<50 R<50
Chlormequatchloride 7x10-7 2x104 1 x104 - 4x104 1 x10-7 7x10-5 3x10-5 1 x10-5 7x104 Colchicine R<50 R<50 R<50 - - R<50 R<50
Abbreviations: NE, value could not be estimated from the response curve; R<50, maximal response observed for the test chemical at the concentrations tested was below
50% of the maximal 17p-estradiol response; RP, relative potency. aEC50 expresses the concentration of test compound needed to produce 50% of the maximal response
induced by 17,B-estradiol. EC50 values were extrapolated from the response curves in Figures 2 and 3 forthose test compounds inducing responses above 50% of the maximal
17,B-estradiol response. bRP was calculated as the ratio between EC50 for17p3-estradiol and EC50forthe test compound.
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Although most ofthe alkylphenols used
in different products are branched, this
study included the well-defined unbranched
alkylphenols 4-n-OP and 4-n-NP. Binding
affinities to recombinant hER for 4-n-OP
and 4-n-NP in this study were relatively
high, with IC50 values of4.0 and 4.3 FM,
respectively, corresponding to binding
affinities ofapproximately 1/3000th that of
17P-estradiol (Table 3). These affinities did
not differ much from binding affinities to
ER isolated from rainbow trout liver for
mixed isomers of4-tert-OP and 4-NP (31).
4-NP may be released from certain types of
plastic centrifuge tubes and then induce cell
proliferation and increases in progesterone
receptors in MCF-7 cells, and it triggers
mitotic activity in rat endometrium (33). In
this study both 4-n-OP and 4-n-NP
induced cell proliferation and transcrip-
tional activation in MCF-7 cells, albeit to a
different level than that of 17p-estradiol
(Figures 3 and 5). 4-n-OP was the most
potent ofthe two alkylphenols, which is in
accordance with findings ofmost previous
studies (18,31). However, a recent study
reported that 4-NP had higher estrogenic
potency than 4-OP (23). Maximal response
in the proliferation assay was seen at con-
centrations of 10 pM, and toxic effects
occurred at higher concentrations. Both
chemicals were also toxic to the yeast strain
expressing the hER (Figure 4). 4-n-OP
killed the yeast in both laboratories using
this assay and only a weak estrogenic
response was induced at low doses not asso-
ciated with cytotoxicity. 4-n-NP induced a
partial agonistic response in one laboratory
but killed the yeast in the other laboratory.
In a previous study using the same assay
conditions, both 4-tert-OP and 4-NP stim-
ulated 0-galactosidase activity to a similar
extent as 17p-estradiol but with potencies
of 1/1000th and 1/30,000th that of170-
estradiol (35). In another yeast assay using
the strain BJ2407 containing the hER,
overnight incubation with 10 pM 4-OP sig-
nificantly increased j-galactosidase activity
to a similar extent as 17J8-estradiol although
the potency was 1000-fold less than
17rvestradiol (15).
In the assay using Saccharomyces
containing the rtER, a strong response was
induced by both alkylphenols at 10 pM
(Figure 7). Differences in the primary
structure of especially the N-terminal
domain of rtER and hER and differences
in binding affinity for 17i-estradiol
between the two ER receptors have been
reported (53). Thus, the discrepancy in
the results between yeast containing the
hER and yeast containing the rtER might
be due to differences in transactivation of
I-galactosidase activity caused by differ-
ences in binding affinities between the two
receptors and the alkylphenols tested.
Another possible explanation is that the
shorter incubation time used in the rtER
yeast assay (4 hr) than in the hER yeast
assay (72 hr) may preclude a toxic effect.
Although both alkylphenols activated
the rtER in the yeast assay, neither 4-n-OP
nor 4-n-NP induced increased vitel-
logenin synthesis in juvenile rainbow
trout at the doses investigated in this
study (Figure 2). NP induces vitellogenin
production in rainbow trout after expo-
sure to only 10 ppb NP in a flow-through
system for 72 hr (32). In addition, 4-NP
and 4-tert-OP both induced synthesis of
vitellogenin in rainbow trout hepatocytes
in vitro (63). In rodents, low doses ofNP
(10 pg/day for 11 days) increased prolifer-
ation of the mammary epithelial cell of
female rats by 200% compared to that of
controls (34).
The apparent discrepancy between
some of the results obtained for the two
alkylphenols is probably due to the use of
either unbranched or technical grade
isomer mixtures, and interpretation is
hampered by the lack ofdetail on the iso-
mer characteristics of the alkylphenols
used. The estrogenic potency ofalkylphe-
nols is likely to depend on both the posi-
tion and branching of the alkyl group
(35). 4-Tertiary branched alkyl groups of
six to eight carbons located at the para
position were most estrogenic and approx-
imately 30-fold more potent than 4 nor-
mal and 4 secondary equivalents when
evaluated in a yeast assay (35). In another
yeast assay technical grade NP was approx-
imately twice as potent as straight-chain n-
NP in inducing 3-galactosidase activity
after 18 hr of incubation (23). In the
rodent uterotropic assay technical NP, but
not n-NP, induced a dose-related positive
response (12).
With regard to the phthalates, both
BBP and DBP bind to the ER from rain-
bow trout liver and induce proliferation
and reporter gene activation in MCF-7
cells (6) and in yeast (28). BBP and DBP
were the most potent of a range ofphtha-
late esters evaluated in a recombinant yeast
assay inducing maximal responses of 50
and 35% of the 170-estradiol response,
respectively. The most potent compound,
BBP, was approximately 1,000,000-fold
less potent than estradiol (28). In the pre-
sent study BBP bound to the recombinant
hER (but not rabbit uterus ER) (Table 3)
and induced full or partial estrogenic
responses in the E-SCREEN (Figure 3)
and weak estrogenic responses in the
reporter gene assays in MCF-7 cells (Figure
5), yeast (Figures 4,7), and in the in vivo
vitellogenin assay. The potency ofBBP in
the E-SCREEN was estimated to be 1/
10,000,000 to 1/1,000,000 that of 1U7P-
estradiol. DBP was inactive in most ofthe
assays, except the two MCF-7 cell assays in
which a weak or partial est-rogenic response
was induced. Hence, the results obtained
are in good agreement with previous find-
ings that BBP and DBP are weakly estro-
genic compounds, with BBP being the
most potent.
Several organochlorine pesticides
induce estrogenic responses in vivo (64)
and in vitro (25,65). In agreement with
other studies (21), a strong binding affinity
of o,p'-DDT was found for recombinant
hER, and a strong estrogenic response was
demonstrated in MCF-7 cells either by
increased proliferation or induction of
transcriptional activity. The relatively low
estrogenic response induced in yeast
expressing the hER was similar to previ-
ously reported results when the same yeast
strain and assay conditions were used (27)
and may be caused by reduced availability
of o,p'-DDT due to adherence to the sur-
face ofthe assay plate. Thus, a higher and
steeper response curve was induced if o,p'-
DDT was added directly to the medium
(Figure 8). In a study using another yeast
strain (BJ2407) and direct addition ofo,p'-
DDT to the medium, a full estrogenic
response to 1 and 10 pM o,p'-DDT was
observed (21). The major DDT metabolite
p,p'-DDE had a lower binding affinity for
the ER and showed less estrogenicity in
MCF-7 cells than o,p'-DDT-in agree-
ment with earlier reports (43). In yeast,
p,p'-DDE was unable to induce ,B-galac-
tosidase activity at the concentrations
tested. Besides the weak estrogenicity of
p,p'-DDE, this compound is an androgen
receptor antagonist (43).
In agreement with other studies,
methoxychlor induced an estrogenic
response in MCF-7 cells (5). A positive
response was also seen in the yeast (Figures
4,7), thus indicating that both MCF-7
cells and yeast can provide the appropriate
metabolic transformation of methoxy-
chlor to the estrogenic demethylated
metabolite (40).
Endosulfan induces proliferation of
MCF-cells at 10 pM to a level similar to
that of 10 pM 171-estradiol and induces
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progesterone receptors (5).The binding
affinity of endosulfan for ER was approxi-
mately 1/10,000th that of 17,B-estradiol
(5), which was also found for recombinant
hER in this study (Table 3). A weak
increase in 3-galactosidase activity induced
by endosulfan has been reported in the
yeast strain BJ2407 expressing the hER
(66). In the present study endosulfan
induced only a weak proliferative response
in MCF-7 cells (Figure 3) and in yeast
expressing the rtER (Figure 7) and no
estrogenic response in the transactivation
assay in MCF-7 cells (Figure 5) or in the
yeast assays containing the hER (Figure 4).
None ofthe pesticides-o,p'-DDT, p,p'-
DDE, methoxychlor, or endosulfan-
induced increased vitellogenin production
in rainbow trout in this study (Figure 2).
Repeated doses of o,p'-DDT, but not p,p'-
DDE, induced vitellogenin in rainbow trout
(67) at a total dose similar to the dose level
used as a single dose in this study. In a study
in catfish endosulfan caused a decrease in
vitellogenesis that could be partially reversed
by estradiol treatment (42).
Chlormequat chloride was included to
represent a chlorinated chemical without a
ring structure. To our knowledge this com-
pound has not previously been tested for
estrogenic effects in vitro or in vivo. In this
study an estrogenic response was induced
in several of the assay systems. After the
termination of the blinded comparison
study, another batch ofchlormequat chlo-
ride from the same supplier (Ehrenstorfer)
together with chlormequat chloride from
another supplier (Riedel-de Hien) were
retested in the E-SCREEN in laboratory 1
and in the reporter gene expression assay in
MCF-7 cells in laboratory 7. Neither cell
proliferation nor reporter gene expression
was increased above control level for these
two samples (data not shown). Hence, it
was not possible to reproduce the estro-
genic response to chlormequat chloride
observed in the comparison study. The
estrogenic response could potentially be
due to contamination during preparation
of the test sample or during synthesis or
storage ofthe batch used.
The present comparison study provides
evidence on several important aspects.
Ethanol is often used as a solvent for test
substances in different assay systems,
including those involved in this study. In
one study ethanol in concentrations
between 0.0001 and 10% increased the
growth, as estimated by 3H-thymidine
uptake in MCF-7 cells (68). To our
knowledge, similar effects have not been
observed in other studies on MCF-7 cells,
and the laboratories participating in this
study have no previous experience of
ethanol-induced responses in the assays.
Hence, the estrogenic response to the
ethanol observed in the most sensitive assay
systems in this study could theoretically be
due to a sporadic ethanol-induced response,
but it is most likely due to a cross-contami-
nation by one ofthe three potent estrogens
that were handled immediately before the
vials with solvent controls were prepared. If
the ethanol was contaminated with one of
the strong estrogens included in the test
panel, it must have occurred after the
preparation ofall the other test compounds.
Therefore, the results obtained should not
be disregarded because of the possibility of
contamination. The overall findings are in
good agreement with those of previous
studies, and some chemicals induced
responses lower than the ethanol. Further,
for each test substance aliquots from the
same stock solution were transferred to the
test vials so that all participating laborato-
ries (except for the vitellogenin assay in lab-
oratory 9) tested exactly the same solutions.
The inclusion ofa solvent control prepared
together with strongly estrogenic chemicals
shows that laboratory contamination can
occur despite rigorous hygiene procedures.
Indeed, that possibility was considered
when the study was designed. This experi-
ence therefore emphasizes that results iden-
tifying a new estrogenic compound should
be reproducible in more than one labora-
tory, as there will always be a risk ofconta-
mination with potent estrogens present in
the laboratory. In addition, it shows the
importance of meticulous procedures
for handling potent estrogens. Inclusion of
solvent controls prepared before, con-
currently, and after preparation of the test
substances is recommended to document
that no cross-contamination has occurred.
Pretesting solvent controls in at least one
sensitive assay system before distribution to
the other participating laboratories could
also be considered.
Finally, the data also allow a prelimi-
nary assessment of the validity of the tests
used, based on the results obtained with
similar methods used in different laborato-
ries and with different methods based on
related principles. The advantages and
disadvantages must be carefully considered,
in particular when choosing one or more
tests for screening purposes.
The LBAs determine the degree of
binding to ER in a simplified test situation
and they cannot discriminate between
antiestrogens and estrogens. The binding
assay based on recombinant hER is sensi-
tive, as determined from the number of
substances that are positive in this assay,
but estrogenic metabolites of the test
chemicals will not be detected. In the bind-
ing assay based on ER from rabbit uterine
tissue, some metabolism seems to occur,
probably because ofthe presence of metab-
olizing enzymes in the cytosol during incu-
bation. This assay has a lower sensitivity
than the one using recombinant hER and
it is more cumbersome.
Although cell cultures involve disadva-
ntages associated with maintaining the cell
line and avoiding contamination, their use
in test systems offers definite advantages.
The estrogenic response induced by metho-
xychlor and bisphenol A dimethacrylate in
MCF-7 cells as well as in yeast cultures
indicates that both cell types have the meta-
bolic capacity to convert at least some proe-
strogens into estrogens. The E-SCREEN
assay and the transient reporter gene expres-
sion assay in MCF-7 cells are capable of
discriminating between antiestrogens and
estrogens, and a high sensitivity is indicated
by the response to most of the test chemi-
cals at low concentrations. The E-SCREEN
is easier to perform than the transient
reporter gene activation assay, but transacti-
vation may reveal more information regard-
ing the ability of the test compounds to
activate the ER. If the reporter gene con-
struct could be stably transfected into the
MCF-7 cells, this assay would be much eas-
ier to perform and more suitable for screen-
ing purposes. The proliferation assay
carried out in three laboratories showed
essentially identical results for some of the
chemicals but somewhat deviating results
for other chemicals. Some of that discrep-
ancy may be due to slight methodological
differences (5% CD-treated FBS versus
10% CD-treated serum human serum, cell
counting versus SRB staining, plate size,
etc). Further standardization of this assay
may further improve the reproducibility of
the results.
The yeast assays cannot necessarily
discriminate between estrogenic and antie-
strogenic compounds. Another disadvan-
tage is that yeast seems to be rather sensitive
to toxic effects of chemicals (e.g., 4-n-NP
and 4-n-OP), which may complicate the
interpretation of the results. Toxic effects
probably account for at least part of the
discrepancy between results obtained in the
different yeast assays. In the assays using
DYI50 expressing the hER and the assay
using Saccharomyces expressing the rtER,
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only a single relatively high concentration
(10 pM) ofeach test substance was used. In
the former assay only a few chemicals
showed a positive response after an 18-hr
incubation. In several cases the response
was less than the response in untreated con-
trols, thus indicating a toxic response. This
observation illustrates the importance of
using several concentrations ofthe test sub-
stances or ensuring that the concentrations
used are nontoxic to the assay system to
avoid false negatives due to estrogenic
responses hidden by toxicity. In the
Saccharomyces assay with the rtER, toxicity
may have been minimized by a shorter
incubation time of4 hr. Hence, the influ-
ence on the results ofthe specific assay con-
ditions as well as the specific yeast strain,
the origin ofthe ER, and the reporter gene
construct must be further documented.
Because the application method ofthe test
compounds and the incubation time influ-
enced the results, the assays must be opti-
mized to obtain reliable results. When
standardized assay conditions are used in
different laboratories, the results obtained
with the Saccharomyces expressing the hER
appear reproducible.
The vitellogenin assay in rainbow trout
is more cumbersome and expensive but has
the advantage ofbeing a short-term in vivo
system. This method is less suitable for
preliminary screening but may be useful
for retesting chemicals that are positive in
one of the preliminary assays. However,
the exact procedure for the vitellogenin
assay should be further evaluated regarding
exposure time and dose level to avoid false
negative results.
The specificity of the methods cannot
be determined in this study because the
true estrogenic response is unknown for
several of the test compounds. However,
as a first rapid screening assay for estro-
genicity ofchemicals, at least two assays
should probably be carried out with a view
to high sensitivity, standardized condi-
tions, and ease in performance. Realistic
candidates are the recombinant hER LBA
and the E-SCREEN, as these assays have
high sensitivity, are easy to perform, and in
combination provide information on both
receptor binding and a cellular response.
In the future development ofshort-term
tests, additional comparisons will be neces-
sary, standardization will be obligatory,
and, quite likely, no single test will be
found valid either for exclusion or for verifi-
cation ofestrogenicity. Better information
on the metabolic capacity ofthe test systems
is needed, and addition of metabolic
enzymes to the in vitro assays may improve
their reliability and comparability. Also, the
subtype ofER in the individual assays must
be taken into account. Although important
differences between the tests have been doc-
umented in this study, the results suggest
that it will be feasible to design a battery of
tests for screening of estrogenicity of
environmental chemicals.
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